Request for Nominations of Candidates To Serve on the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment, Centers for Disease Control and Prevention, Health Resources and Services Administration, 1380 [2014-00045]
Download as PDF
<![CDATA[
1380
Federal Register / Vol. 79, No. 5 / Wednesday, January 8, 2014 / Notices
if it is unclear whether the third party is
living or deceased; or (c) the information is
unrelated or irrelevant to the purpose of the
disclosure.
The Board will take reasonable steps to
ensure that individuals making public
comment are aware of the fact that their
comments (including their name, if provided)
will appear in a transcript of the meeting
posted on a public Web site. Such reasonable
steps include: (a) A statement read at the start
of each public comment period stating that
transcripts will be posted and names of
speakers will not be redacted; (b) A printed
copy of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public
comments; (c) A statement such as outlined
in (a) above will also appear with the agenda
for a Board Meeting when it is posted on the
NIOSH Web site; (d) A statement such as in
(a) above will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings.
Contact Person For More Information:
Theodore Katz, M.P.A., Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road NE.,
MS E–20, Atlanta, GA 30333, Telephone:
(513) 533–6800, Toll Free: 1–800–CDC–
INFO, Email: dcas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register Notices
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Gary J. Johnson,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–00042 Filed 1–7–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
mstockstill on DSK4VPTVN1PROD with NOTICES
Request for Nominations of
Candidates To Serve on the CDC/
HRSA Advisory Committee on HIV,
Viral Hepatitis and STD Prevention and
Treatment, Centers for Disease Control
and Prevention, Health Resources and
Services Administration
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for possible membership
on the CDC/HRSA Advisory Committee
on HIV, Viral Hepatitis and STD
Prevention and Treatment
(CHACHSPT).
The CHACHSPT provides advice to
the Secretary, HHS; the Director, CDC;
and the Administrator, Health
Resources and Services Administration
(HRSA), on objectives, strategies,
policies, and priorities for HIV, Viral
VerDate Mar<15>2010
16:42 Jan 07, 2014
Jkt 232001
Hepatitis, and STD prevention and
treatment efforts including surveillance
of HIV infection, AIDS, Viral Hepatitis,
other STDs, and related behaviors;
epidemiologic, behavioral, health
services, and laboratory research on
HIV/AIDS, Viral Hepatitis, and other
STDs; identification of policy issues
related to HIV/Viral Hepatitis/STD
professional education, patient
healthcare delivery, and prevention
services; agency policies about
prevention of HIV/AIDS, Viral Hepatitis
and other STDs, treatment, healthcare
delivery, and research and training;
strategic issues influencing the ability of
CDC and HRSA to fulfill their missions
of providing prevention and treatment
services; programmatic efforts to
prevent and treat HIV, Viral Hepatitis,
and other STDs; and support to the
agencies in their development of
responses to emerging health needs
related to HIV, Viral Hepatitis and other
STDs.
The CHACHSPT consists of 18
experts knowledgeable in the fields of
public health, epidemiology, laboratory
practices, immunology, infectious
diseases, drug abuse, behavioral science,
health education, healthcare delivery,
state health programs, clinical care,
preventive health, medical education,
health services and clinical research,
and healthcare financing, who are
selected by the Secretary of the U.S.
Department of Health and Human
Services (HHS).
Nominations are being sought for
individuals who have expertise and
qualifications necessary to contribute to
the accomplishments of the Committee’s
objectives.
Nominees will be selected from
experts having experience in HIV/AIDS,
Viral Hepatitis and STD prevention,
control and treatment. Experts in the
disciplines of epidemiology, laboratory
practice, immunology, infectious
diseases, drug abuse, behavioral science,
health education, healthcare delivery,
state health programs, clinical care,
preventive health, medical education,
health services and clinical research,
healthcare financing and other related
disciplines will be considered. The
committee shall have at least four
members who shall be persons living
with HIV/AIDS.
Members may be invited to serve for
terms of up to four years. The HHS
policy stipulates that committee
membership be balanced in terms of
professional training and background,
points of view represented and the
committee’s function. Consideration is
given to a broad representation of
geographic areas within the U.S., with
equitable representation of the sexes,
PO 00000
Frm 00019
Fmt 4703
Sfmt 4703
ethnic and racial minorities, and
persons with disabilities. Nominees
must be U.S. citizens, and cannot be
full-time employees of the U.S.
Government.
Candidates should submit the
following items:
• Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address)
• A letter of recommendation from
person(s) not employed by the U.S.
Department of Health and Human
Services
• A statement indicating the
nominee’s willingness to serve as a
potential member of the Committee.
Nominations should be submitted
electronically to zkr7@cdc.gov or in
writing, to: Margie Scott-Cseh,
Committee Management Specialist,
NCHHSTP, CDC, 1600 Clifton Road NE.,
Mailstop: E07, Atlanta, GA 30333. All
nominations must be postmarked by
April 30, 2014.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Gary J. Johnson
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2014–00045 Filed 1–7–14; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Request for Nominations of
Candidates To Serve on the Advisory
Council for the Elimination of
Tuberculosis, Centers for Disease
Control and Prevention, Department of
Health and Human Services
The Centers for Disease Control and
Prevention (CDC) is soliciting
nominations for possible membership
on the Advisory Council for the
Elimination of Tuberculosis (ACET).
ACET provides advice and
recommendations to the Secretary,
Department of Health and Human
Services (HHS); the Assistant Secretary
of Health; and the Director, CDC,
regarding program policies, strategies,
objectives, and priorities; address the
development and application of new
E:\FR\FM\08JAN1.SGM
08JAN1
]]>Agencies
[Federal Register Volume 79, Number 5 (Wednesday, January 8, 2014)]
[Notices]
[Page 1380]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-00045]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Request for Nominations of Candidates To Serve on the CDC/HRSA
Advisory Committee on HIV, Viral Hepatitis and STD Prevention and
Treatment, Centers for Disease Control and Prevention, Health Resources
and Services Administration
The Centers for Disease Control and Prevention (CDC) is soliciting
nominations for possible membership on the CDC/HRSA Advisory Committee
on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT).
The CHACHSPT provides advice to the Secretary, HHS; the Director,
CDC; and the Administrator, Health Resources and Services
Administration (HRSA), on objectives, strategies, policies, and
priorities for HIV, Viral Hepatitis, and STD prevention and treatment
efforts including surveillance of HIV infection, AIDS, Viral Hepatitis,
other STDs, and related behaviors; epidemiologic, behavioral, health
services, and laboratory research on HIV/AIDS, Viral Hepatitis, and
other STDs; identification of policy issues related to HIV/Viral
Hepatitis/STD professional education, patient healthcare delivery, and
prevention services; agency policies about prevention of HIV/AIDS,
Viral Hepatitis and other STDs, treatment, healthcare delivery, and
research and training; strategic issues influencing the ability of CDC
and HRSA to fulfill their missions of providing prevention and
treatment services; programmatic efforts to prevent and treat HIV,
Viral Hepatitis, and other STDs; and support to the agencies in their
development of responses to emerging health needs related to HIV, Viral
Hepatitis and other STDs.
The CHACHSPT consists of 18 experts knowledgeable in the fields of
public health, epidemiology, laboratory practices, immunology,
infectious diseases, drug abuse, behavioral science, health education,
healthcare delivery, state health programs, clinical care, preventive
health, medical education, health services and clinical research, and
healthcare financing, who are selected by the Secretary of the U.S.
Department of Health and Human Services (HHS).
Nominations are being sought for individuals who have expertise and
qualifications necessary to contribute to the accomplishments of the
Committee's objectives.
Nominees will be selected from experts having experience in HIV/
AIDS, Viral Hepatitis and STD prevention, control and treatment.
Experts in the disciplines of epidemiology, laboratory practice,
immunology, infectious diseases, drug abuse, behavioral science, health
education, healthcare delivery, state health programs, clinical care,
preventive health, medical education, health services and clinical
research, healthcare financing and other related disciplines will be
considered. The committee shall have at least four members who shall be
persons living with HIV/AIDS.
Members may be invited to serve for terms of up to four years. The
HHS policy stipulates that committee membership be balanced in terms of
professional training and background, points of view represented and
the committee's function. Consideration is given to a broad
representation of geographic areas within the U.S., with equitable
representation of the sexes, ethnic and racial minorities, and persons
with disabilities. Nominees must be U.S. citizens, and cannot be full-
time employees of the U.S. Government.
Candidates should submit the following items:
Current curriculum vitae, including complete contact
information (telephone numbers, mailing address, email address)
A letter of recommendation from person(s) not employed by
the U.S. Department of Health and Human Services
A statement indicating the nominee's willingness to serve
as a potential member of the Committee.
Nominations should be submitted electronically to zkr7@cdc.gov or
in writing, to: Margie Scott-Cseh, Committee Management Specialist,
NCHHSTP, CDC, 1600 Clifton Road NE., Mailstop: E07, Atlanta, GA 30333.
All nominations must be postmarked by April 30, 2014.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and the Agency
for Toxic Substances and Disease Registry.
Gary J. Johnson
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2014-00045 Filed 1-7-14; 8:45 am]
BILLING CODE 4163-18-P
